Statement by FDA Commissioner Scott Gottlieb, M.D., on the formation of a new work group to develop focused drug importation policy options to address access challenges related to certain sole-source medicines with limited patient availability, but no blocking patents or exclusivities - FDA Press Releases

FDA forms work group on drug importation policy options to address certain patient access challenges

from Food and Drug Administration--Press Releases https://ift.tt/2LsRPfC
via IFTTT